ICPT - INTERCEPT PHARMACEUTICALS IN
This page shows which of the focused investors we track hold ICPT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2021 it was held by 1 manager with an aggregate reported value of $42K, which is 0.00% of the combined portfolio.
As of Q3 2021, 1 tracked institutional manager held ICPT (INTERCEPT PHARMACEUTICALS IN) with an aggregate reported value of $42K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ICPT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2021
- Ticker
- ICPT
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Lee Ainslie - Maverick Capital | 0.00% | Reduce -94.2% | 2,827 | $42K |
Loading holder history for ICPT…